Actimed News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Actimed. Real-time updates on events, politics, business and more.

Actimed to use extra funding for cancer cachexia cure

August 22, 2023

Actimed Therapeutics Ltd will put some of its additional funding of £4.75 million ($6 million) towards its attempt to provide the world’s first cure for cancer cachexia.

City Of United Kingdom Robin Bhattacherjee United Kingdom Based Actimed Therapeutics Patient Centricity

Source: outsourcing-pharma.com

Actimed Therapeutics secures significant new patent, extending IP coverage of its lead compound for use in key indication

May 4, 2022

Provides extended UK patent coverage relating to lead compound S-pindolol benzoate (ACM-001.1) to 2040. International patent application also filed in March 2021. LONDON, May 4, 2022 /PRNewswire/

United Kingdom City Of Frazer Hall Robin Bhattacherjee Kostenloser Wertpapierhandel Stefan Anker

Source: finanznachrichten.de

Actimed Therapeutics Achieves Major Corporate Milestone - Initiation of first clinical study of new salt of S-pindolol (ACM-001.1)

December 14, 2021

- Actimed Therapeutics initiates the company's first clinical study of the pharmacokinetics and pharmacodynamics (PK/PD) for a new salt of S-pindolol (ACM-001.1) - This study is a prelude